Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
Anti-Cancer Drugs
|
April 23, 2019
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer
Ignacio Romero, Pedro Mallol, Ana Santaballa, et al.
Cancer
|
November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 23, 2022
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study
Alessandro D Santin, Ignace Vergote, Antonio González-Martín, et al.
BMC Cancer
|
July 5, 2024
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study
María Jesús Rubio, Aránzazu Manzano, Luis Miguel de Sande, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 24, 2024
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer
Alejandro Perez-Fidalgo, Barbara Schmalfeldt, Angela George, et al.
JCO Precision Oncology
|
January 30, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, et al.
The Lancet. Respiratory Medicine
|
July 5, 2021
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study
Elisa Estenssoro, Cecilia I Loudet, Fernando G Ríos, et al.
Antioxidants (Basel, Switzerland)
|
August 26, 2023
NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3
Belén Cuevas-López, Edgar Ignacio Romero-Ramirez, Fernando E García-Arroyo, et al.
Oncogene
|
July 7, 2019
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways
Blanca Majem, Alfonso Parrilla, Carlos Jiménez, et al.
Journal of Critical Care
|
March 29, 2022
Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: A prospective cohort study
Elisa Estenssoro, Cecilia I Loudet, Arnaldo Dubin, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
Anti-Cancer Drugs
|
April 23, 2019
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer
Ignacio Romero, Pedro Mallol, Ana Santaballa, et al.
Cancer
|
November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 23, 2022
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study
Alessandro D Santin, Ignace Vergote, Antonio González-Martín, et al.
BMC Cancer
|
July 5, 2024
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study
María Jesús Rubio, Aránzazu Manzano, Luis Miguel de Sande, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 24, 2024
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer
Alejandro Perez-Fidalgo, Barbara Schmalfeldt, Angela George, et al.
JCO Precision Oncology
|
January 30, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, et al.
The Lancet. Respiratory Medicine
|
July 5, 2021
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study
Elisa Estenssoro, Cecilia I Loudet, Fernando G Ríos, et al.
Antioxidants (Basel, Switzerland)
|
August 26, 2023
NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3
Belén Cuevas-López, Edgar Ignacio Romero-Ramirez, Fernando E García-Arroyo, et al.
Oncogene
|
July 7, 2019
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways
Blanca Majem, Alfonso Parrilla, Carlos Jiménez, et al.
Journal of Critical Care
|
March 29, 2022
Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: A prospective cohort study
Elisa Estenssoro, Cecilia I Loudet, Arnaldo Dubin, et al.
Page
of 12